New Risk • Jul 02
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Revenue is less than US$1m (CA$144k revenue, or US$102k). Market cap is less than US$10m (CA$8.21m market cap, or US$5.79m). Minor Risk Shareholders have been diluted in the past year (25% increase in shares outstanding). New Risk • Jun 28
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 25% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (CA$144k revenue, or US$102k). Market cap is less than US$10m (CA$6.95m market cap, or US$4.90m). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Shareholders have been diluted in the past year (25% increase in shares outstanding). Announcement • Jun 18
Avricore Health Inc. announced that it has received CAD 1.254 million in funding On June 16, 2026, Avricore Health Inc. has closed the transaction. The company will now issue 25,080,000 unit at an issue price of CAD 0.05 for the proceeds of CAD 1,254,000. The company paid finders' fees of CAD 54,600 and issue 1,092,000 non-transferable finders' warrants to Canaccord Genuity Corp. an arm's-length finder. Insiders participated in the aggregate amount of CAD 200,000 for 4,000,000 units. Certain directors and officers have participated in the Private Placement. 
